Project
A Phase 1, Open-label, Multicenter Study to Assess Safety, Tolerability, PK, and Efficacy of MK-6598 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Ongoing - recruitment active ยท 2023 until 2028
Hess Dagmar, Donno Monica, Quinter Janine
No results found.